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 The objective of this study was to determine the prevalence of Bibersteinia trehalosi 
(B. trehalosi) in feedlot cattle, as well as develop an improved method of detection via 
quantitative Polymerase Chain Reaction (qPCR).  Nasopharyngeal swab samples were taken 
from cattle, located in five different Kansas feedlots, providing 188 samples.  The samples 
were tested for B. trehalosi, Mannheimia haemolytica, Pasteurella multocida, Histophilus 
somni, and Mycoplasma bovis by conventional culture methods.  DNA was extracted from 
the original swab sample transport media.  After extraction the samples were run on qPCR 
using an assay that was developed as part of this study.  It was determined that the assay will 
need further optimization to enhance the sensitivity and specificity to B. trehalosi.  Overall 
one B. trehalosi was detected, indicating a low prevalence among the samples analyzed. 
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 The animal health sector is a major part of the agriculture industry.  Biological and 
Pharmaceutical companies are constantly working to stay on the cutting edge of treatments 
for disease and implementing preventative measures to maintain herd health.  As time goes 
on, an increasing number of pathogens are recognized as being a cause for an animal 
becoming ill.  With progressing research, and a development of knowledge for disease-
causing microorganisms, comes the need to determine what infectious agents should be of 
primary concern for producers, veterinarians, and biological/pharmaceutical manufacturers. 
 Prevalence data is an important factor in determining what pathogens should be of 
concern.  The more often a specific microorganism is recognized and confirmed as the cause 
of a disease the greater the need for a vaccine.  Prevalence studies are also essential in 
gaining more knowledge on an emerging infectious agent that may have limited literature 
pertaining to it.  Animal health companies take prevalence data, and other studies associated 
with the pathogen in question, into consideration when deciding to develop a new product.   
 Advancements in diagnostic and molecular biology techniques are necessary for 
animal health companies to stay on the forefront of medicine.  In order to obtain data relating 
to a pathogen, multiple diagnostic tools can be used, such as polymerase chain reaction 
(PCR), quantitative PCR (qPCR), genetic sequencing, etc.  These techniques vary in the 
amount of time and expense it takes to garner results.  Currently, qPCR is generally 
recognized as a quicker and more cost efficient technique.  Therefore, development of qPCR 
assays against new or emerging microorganisms is paramount. 
           





 Bovine respiratory disease complex (BRDC) is the leading cause of morbidity and 
mortality among feedlot cattle in the United States and Canada, as well as exported cattle in 
Australia.  This results in economic losses due to the cost of treatments, and a reduction in 
the feed efficiency and overall productivity of the cattle.  Some clinical signs of BRDC 
include: fever, coughing, loss of appetite, depression, shallow breathing, and nasal and eye 
discharge.  There are multiple factors that can lead to the onset of BRDC including; 
environmental stressors, travel related stress, and comingling of infected cattle (Holman et 
al., 2015; Moore et al., 2015; Anton et al., 2016).  Several pathogens are considered to be 
involved in the complex, allowing for the manifestation of a respiratory infection.  These 
pathogens include a number of both viruses and bacteria.   
 The viruses associated include: Bovine herpesvirus (BHV), Bovine respiratory 
syncytial virus (BRSV), Bovine viral diarrhea virus (BVDV), Bovine parainfluenza virus 3 
(PI-3), bovine coronavirus (BoCV), bovine rhinoviruses, and bovine adenoviruses. Of these 
BHV, BRSV, and PI-3 are the most common respiratory pathogens.  Additionally, BVDV is 
a significant predisposing pathogen (Moore et al., 2015).  Studies have been published 
worldwide looking into prevalence data of BRSV.  These studies have found that BRSV is 
present in herds all across the globe and can also prompt secondary infections brought on by 
bacteria (Sacco et al., 2014). 
 The bacteria most commonly connected to BRDC consist of: Mannheimia 
haemolytica (M. haemolytica), Histophilus somni (H. somni), Pasteurella multocida (P. 
multocida), Bibersteinia trehalosi (B. trehalosi), Mycoplasma bovis (M. bovis), and 




these bacteria are considered to be opportunistic pathogens, taking advantage of a weakened 
immune system.  They are housed within the nasopharynx of the cattle as commensals, and 
do not cause illness until the immune system is compromised by either a viral infection or  
stress, thus allowing for the bacteria to enter the lungs (Confer, 2009; Holman et al., 2015; 
Anton et al., 2016).  The most recent bacteria added to the list of BRDC pathogens is B. 
trehalosi (Confer, 2009).   
 Bibersteinia trehalosi is a gram negative, rod-shaped, nonmotile bacterium that is 
commonly found in bighorn sheep (Ovis canadensis) and ruminants worldwide (Blackall et 
al., 2007; Villard et al., 2008; Kugadas et al., 2016).  On a blood agar plate B. trehalosi 
colonies appear to be greyish or yellowish in color, round in configuration, and semi-
transparent at the periphery with beta-hemolysis present (Blackall et al. 2007).  Bibersteinia 
trehalosi was formerly classified as Pasteurella haemolytica biotype T and M. haemolytica 
was classified as Pasteurella haemolytica biotype A.  The difference separating the two 
being that B. trehalosi ferments trehalose and M. haemolytica utilizes arabinose (Blackall et 
al., 2007, Villard et al., 2008).  This bacterium is a known cause of pneumonia as well as 
septicemia in bighorn sheep (Besser et al., 2012; Dassanayake et al., 2013).    Additionally, it 
is the most common bacteria found in the tonsils of clinically normal American bison 
(Bowersock et al., 2014).  Mannheimia haemolytica and B. trehalosi are the two most 
common pathogens isolated from pneumonia cases in sheep, with B. trehalosi being isolated 
more frequently than the former (Dassanayake et al., 2013; Drew et al., 2013; Kugdas et al., 
2016).  It is believed that capsular serotypes T3, T3, and T10 are responsible for causing 




 Recently there have been cases of B. trehalosi presence in cattle with respiratory 
disease, as well as causing hemorrhages in the epicardium, and a case of Subcutaneous 
Botryomycosis (Spagnoli et al., 2012; Harhay et al., 2014; British Veterinary Association 
Veterinary Record, 2015).  Signs of an infection of B. trehalosi range from pneumonia in 
cattle to sudden death with lungs often having exudative fibrinous pneumonia, bronchiolitis, 
and alveolitis.  It has also been implied in trade journal articles that the bacterium is on the 
rise (Newport 2017).  Unpublished diagnostic laboratory data from Texas Vet Lab Inc. 
(TVL) in San Angelo, Texas suggests that B. trehalosi can be found in the lungs of cattle.  
This is also concurrent with cattle of the United Kingdom (Bowersock et al. 2014).  In 
February of 2015, the Animal and Plant Health Agency (APHA), located in the United 
Kingdom, published an October of 2014 disease surveillance report.  In this report, there 
were six out of a group of 20 market-bought calves that died due to an infection of B. 
trehalosi.    
 One objective of this study was to determine the prevalence of B. trehalosi in 
nasopharyngeal samples of feedlot cattle.  This was done in order to be an aid in determining 
whether or not the bacteria can be considered a primary pathogen in relation to the Bovine 
Respiratory Disease Complex. 
 Prevalence data has been reported for M. haemolytica, P. multocida, H. somni, and M. 
bovis but not for B. trehalosi (Confer, 2009; Holman et al., 2015).  In order for there to be a 
proper representation of B. trehalosi prevalence data, a time efficient form of detection is 
needed.  This is the second objective of the study; to develop and validate a one-step 
quantitative polymerase chain reaction (qPCR) assay specific to B. trehalosi.  The current 




developed using genes from both B. trehalosi and M. haemolytica, creating primers for each 
species based on the regions of least similarity.  The primers are used with PCR and then 
samples are examined using gel electrophoresis.  Deciphering whether the sample was M. 
haemolytica or B. trehalosi is based on where bands form in the gel.  This current method is a 
time consuming process, and a qPCR assay has the potential to significantly decrease the 






















MATERIALS AND METHODS 
 Sampling for this study was conducted under veterinary supervision, and no 
experimental research was conducted directly on the cattle themselves.  It was performed as a 
part of standard commercial husbandry practices under standard conditions; therefore, the 
IACUC committee approval was waived by the Angelo State University IACUC committee 
chair. 
Sample Collection 
 Nasopharyngeal swab samples were collected by feedlot personnel from 188 feedlot 
cattle of varying health and age, in order to gather data for analysis.  Five different feedlots in 
Kansas were visited, and the cattle sampled were broken down into three different types: 
fresh cattle, new pull, and repeat.  A fourth type of ‘N/A’ was assigned to samples that were 
mailed into the lab with no information on the cattle type.  ‘Fresh Cattle’ are those 
considered to be clinically healthy and continuing feed yard vaccination protocol, or those 
who are new to the feed yard and are beginning the protocol.  ‘New Pull’ cattle were those 
that were brought to the hospital pen for the first treatment based on usual clinical signs of 
Bovine Respiratory Disease Complex (BRDC) by trained feedlot personnel.  ‘Repeat’ cattle 
are those that have been brought to the hospital pen at least once before for BRDC treatment, 
returned to their original pen, then brought back to the hospital pen due to visual BRDC 
symptoms again.  Table 1 displays the distribution of samples taken from each feedlot 
visited, Location 2 had the greatest proportion of samples taken at 84, followed by Location 
1, Location 3, Location 4, and Location 5.  Table 1 also shows the percentage that each type 
of sample made up for each individual feed yard, as well as, the number and percentage each 
feed yard and sample type made up of the entire sample set.   Out of the four different types  
 
 
Table 1: Frequency and Percentage of Sample Types at Each Feed Yard (n=188)  
 Location 1  Location 2  Location 3  Location 4  Location 5  Total 
Type1 A2 B3 C4  A2 B3 C4  A2 B3 C4  A2 B3 C4  A2 B3 C4  F5 P6 
Fresh 
Cattle 0  0.00 0.00 
 23 27.38 12.23  11 31.43 5.85  17 89.47 9.04  0 0.00 0.00  51 27.13 
New 
Pull 4  9.52 2.13 
 12  14.29 6.38  6 17.14 3.19  2 10.53 1.06  4 50.00 2.13  28 14.89  
Repeat 38 90.48 20.21  49 58.33 26.06  4 11.43 2.13  0 0.00 0.00  4 50.00 2.13  95 50.53 
N/A  0 0.00 0.00  0 0.00 0.00  14 40.00 7.45  0 0.00 0.00  0 0.00 0.00  14 7.45 
Total 42  100.00 22.34  84  100.00 44.68  35  100.00 18.62  19  100.00 10.11  8  100.00 4.26  188 100.00 
1Fresh Cattle = clinically healthy and continuing feed yard vaccination protocol, or are new to the feed yard, New Pull = cattle that have been brought to the hospital pen for the first 
treatment based on clinical signs of BRDC, Repeat = brought to the hospital pen at least once before for BRDC treatment, N/A = samples mailed into the diagnostic lab with no reference 
to the state of the cattle they came from 
2A = Frequency of the sample type from each specific feed yard with the row  titled total being the total number of samples from each feed yard 
3B = Percentage of the samples from the specific feed yard that were the corresponding sample type 
4C = Percentage of the entire sample size with the row titled total being the percentage each feed yard made up of the entire sample size 
5F = Total frequency of the sample type 





of samples the greatest amount (50.53%) were classified as repeats.  The swabs used to 
collect the samples were BBL CultureSwab Collection and Transport System swabs from 
Becton Dickinson (Sparks, MD).  Following sample collection, swabs were kept on ice and 
shipped overnight to the diagnostic lab located in San Angelo, TX.  They were then 
processed by removing the transport media from the original collection tube and placing it in 
a 2ml snap cap micro centrifuge tube (FisherScientific).  One milliliter of 10% glycerol was 
then added to the original collection tube.  This step was done in order to preserve the initial 
swab sample for future use on culture plates.  The micro centrifuge tubes were then stored at 
-80°C until further examination. The original swabs were also stored at -80°C.  The samples 
of the transport liquid in the micro centrifuge tubes underwent gram negative DNA 
extraction using the Wizard Genomic DNA Purification Kit by Promega (Product code 
number A1120).  The Wizard Genomic DNA Purification Kit Quick Protocol FB022 was 
used for the extraction process.  Following DNA extraction, samples were analyzed on 
quantitative PCR (qPCR) using the Applied Biosystems 7500 Fast Real-Time PCR (Foster 
City, CA) machine.  
PCR Method Development  
 The first step of designing the custom qPCR assay was conducted using the Basic 
Local Alignment Search Tool (BLAST) on the National Center for Biotechnology 
Information (NCBI) website.  The O-sialoglycoprotein endopeptidase (gcp) and manganese-
dependent superoxide dismutase (sodA) portions were the initial starting places of the 
Bibersteinia trehalosi (B. trehalosi) and Mannheimia haemolytica (M. heamolytica) genome 
comparison.  When that was found to be inadequate for this study, the process moved on to 




NZ_CP006954.1) sequenced by Harhay et al. (2014) and Kugadas et al. (2016).  The genome 
was selected and searched against the Mannheimia taxon using the nucleotide to nucleotide 
alignment.  It was then compared to a full genome of M. haemolytica  (Genbank accession 
number CP006957) to narrow down to the area of least similarity.  By visually analyzing the 
alignment of the two genomes, the sections of DNA that looked to be least similar were 
noted by the base pair (bp) number location starting with section bp400,021 to bp500,100.  
That specific section of sequence was then entered into the BLAST tool and was again 
blasted against the Mannheimia taxon, resulting in identification of two smaller segments of 
DNA sequence that were visually dissimilar: bp420,001 through bp450,060 and bp460,021 
through bp470,100.  The process was continued in this format until three segments of 
approximately 100 to 500 base pairs were found: bp432,809 through bp432,978, bp460,021 
through bp460,469, and bp466,546 through bp466,643.  These portions of least similarity 
were then found within the full genome of B. trehalosi using the ‘show sequence’ function of 
the genbank reference page.  The bp numbers were highlighted and compared to the gene 
locations in order to identify what gene is coded for in that segment; the included the PTS 
Trehalose transporter subunit IIBC, SH1A/HecA/FhaA exoprotein, and SMI1/KNR4 family 
protein respectively.   
 The sections of the DNA sequence were then entered into the Primer Express 
software to produce a primer/probe set compatible with the qPCR machine.  Once a 
primer/probe set had been selected the entire amplicon region was entered into the alignment 
tool.  This was used to identify any other potential organisms the assay could amplify, 
resulting in a false positive for B. trehalosi.  After analyzing the possible primer sets, the 




set included a forward primer sequence of 5’ TTTTCCTTGCTCACGCCATTA 3’, a probe 
sequence of 5’ CGGTCCAATTGGG 3’, and a reverse primer sequence of 
5’AACCCCATTGCCAATTTCG 3’. Total amplicon length being 56 base pairs long. 
 The forward and reverse primers were first ordered from Integrated DNA 
Technologies custom oligo order in the 100nmole scale. In order to optimize the primer set 
protocol, they were tested on regular Polymerase Chain Reaction (PCR).  The PCR master 
mix consisted of 5µl of 10X Std Taq Rxn Buffer (New England BioLabs, product number 
B9014S) per reaction, 1µl of 10mM dNTP (Applied Biosystems, product number N8080260) 
per reaction, 1µl of 10µM forward primer per reaction, 1µl of 10µM reverse primer per 
reaction, and 0.25µl of Taq DNA Polymerase (New England BioLabs, product number 
M0273S) per reaction.  Magnesium chloride was added to the master mix at a rate of 1.5µl 
per reaction when needed.  Each well used in the PCR contained 8.25µl of the master mix, 1-
2µl of extracted sample depending on DNA concentrations (~100ng of DNA per reaction), 
and the appropriate amount of water to bring the final volume of the well to 50µl.  The final 
PCR parameters for the assay were set at a holding stage of 95°C for 3 minutes, 35 cycles of 
denaturation at 95°C for 30 seconds, 66°C annealing temperature for 1 minute and extension 
at 72°C for 1 minute, followed by 72°C for 5 minutes and finishing at 4°C for infinity.  
Samples of B. trehalosi, M. haemolytica A1, M. haemolytica A2, M. haemolytica A6, 
Pasteurella multocida (P. multocida), and Histophilus somni (H. somni) were used in the 
PCR run to determine if the primer set was capable of amplifying an organism other than B. 
trehalosi.  Following amplification, the test samples were analyzed on a 1.5% agarose gel 
using Tris-Acetate-EDTA (TAE) buffer.   




primers would only amplify B. trehalosi was established, the assay was ordered through 
ThermoFisher with the probe included to be used with the qPCR machine as a simplex assay.  
The master mix for the simplex reactions were made by using 5µl of 1-Step Master Mix per 
reaction, 1µl of the 20X assay per reaction, and 12µl of RNAse-Free water per reaction.  The 
plates were loaded with 18µl of the master mix and 2µl of extracted DNA.  The assay was 
then optimized on the 7500 fast machine starting with the run parameters of the PCR and 
going up one degree on the annealing temperature until B. trehalosi was the only organism of 
the six tested with a positive threshold cycle score (Ct). If the Ct scores were 30 or less at a 
threshold of 0.5 it was considered a positive result.  The final run parameters were a holding 
stage of 95°C for 3 minutes, 35 cycles of denaturation at 95°C for 30 seconds 68°C annealing 
temperature for 1 minute and extension at 72°C for 1 minute. 
 Sensitivity of the assay was tested by growing a known B. trehalosi isolate culture 
from the Texas Vet Lab, Inc. (TVL) diagnostic lab inventory in Tryptic Soy Broth with 
Tryptose (TSTB; see Appendix I).  The bacteria isolate was first streaked out onto a 
Trypticase™ Soy Agar with 5% Sheep Blood (TSA II) plate from FisherScientific.  The plate 
was allowed to incubate at 37°C in a 5% CO2 incubator for approximately 15 hours.  After, 
the isolate was aseptically transferred to the seed tube by utilizing a sterile loop.  The tube 
was then incubated at 37°C in a 5% CO2 incubator for approximately 15hours.  Eight 1:10 
serial dilutions were performed using Phosphate-Buffered saline (PBS).  All samples were 
extracted using the same Promega kit as previously mentioned and run on qPCR.  A colony 
count was taken on the initial sample from the TSTB tube.   
Traditional Culture Methods  




in the 10% glycerol were placed on Trypticase Soy Agar with 5% Sheep Blood (TSA II) 
plates and incubated for approximately 15 hours at 37°C in a 5% CO2 incubator.  After 
incubation, the plates were visually examined by trained lab personnel for bacterial growth; 
colonies were streaked for isolation on a new plate if needed, and biochemical tests of indole, 
oxidase, and catalase reaction were tested.  When the colony appeared gray in color, semi-
transparent at the periphery, and was beta-hemolytic, as well as possessed the desired 
biochemical results, it was considered to be a potential B. trehalosi.  Colony morphology for 
M. haemolytica is similar to that of B. trehalosi with smooth grayish colonies and light 
hemolysis.  P. multocida colonies appear as a grayish color as well but are mucoidal and no 
presence of hemolysis.  H. somni colonies are small with yellow pigment and no hemolysis. 
   Approximately 100µl of the glycerol put in the original swab sample was transferred 
onto a heart infusion agar base Mycoplasma agar plate (see Appendix II), by using a transfer 
pipette covering three-fourths of the plate.  The plates were then incubated at 37°C for 48 
hours in a 5% CO2 incubator to determine if Mycoplasma bovis was present in the sample.  
Typical Mycoplasma colonies are very small, circular in form, appear to have a gray 
peripheral zone on the surface of the agar, and a yellowish centralized zone embedded in the 
agar, commonly referred to as a “fried egg”.  A standard light microscope must be used to 
examine the plates due to the small size of the colonies.   
Confirmation Testing 
 Primary data collected for the PCR development included the Ct  score, which was 
used to determine if the sample was positive for B. trehalosi.  This was then further 
confirmed by assessing the bacterial growth of the blood plate by using biochemical test 




 The previous master mix and PCR protocol mentioned was followed with 
modifications by using M. haemolytica primers as well as modifying the annealing 
temperature and cycles for M. haemolytica detection.  The potential B. trehalosi samples 
were visualized on gel electrophoresis for further confirmation by determining if the samples 
were M. haemolytica positive or negative.  The samples were grown on a plate and then in 
TSTB as previously mentioned prior to PCR.  If no bands were formed in the gel, the 
possibility of the sample being a M. haemolytica was ruled out.   
 The samples that were considered positive for B. trehalosi through culture methods 
and PCR were serotyped using typing sera from TVL inventory provided by the United 
States Department of Agriculture.  A loopful of bacteria was used to make a suspension by 
combining with half a milliliter of sterile water in a micro centrifuge tube and mixing by 
vortex.  A plate agglutination slide was used by placing approximately 20µl of sterile water 
and the typing serums each in their own respective circle.  Seventy to 100µl of suspension 
was gently added and mixed to each serum being tested as well as the negative control circle 
containing water.  The plate was then gently rocked in a circular motion and looked at over 
light in a dark room to determine if clumping was present.  Positive agglutination in the 
various test circles indicated serotype confirmation. 
 Before all PCR runs, the extracted DNA had to be quantified using a Quibit 
fluorometer.  Manufacturer protocol for the Qubit™ dsDNA BR Assay Kit (ThermoFisher 
Scientific) was followed for this process. 
 After all samples had been tested for the initial data collection of the study, a different 
DNA extraction option was tested to see what the effect on the sensitivity of the qPCR assay 




 in TSTB following the procedure previously mentioned.  Eight 1:10 serial dilutions were 
made, and a colony count was conducted.  The samples were then extracted using both the 
Promega kit as well as the DNeasy Blood & Tissue Kit (Cat No./ID: 69504) by Qiagen 
(Germantown, MD).  The manufacturer protocol for the Qiagen kit was followed with 
modifications in the first two steps.  Modifications included spinning down 1ml of bacterial 
liquid sample at 5660 x g for 10 minutes.  The supernatant was removed and 180µl of Buffer 
Animal Tissue Lysis and 20µl of proteinase K were added and vortexed.  The samples were 
then incubated in a water bath of 56°C for approximately 1 to 2 hours with intermittent 
mixing by the vortex approximately every 10 to 15 minutes.  The two sets of extracted DNA 
were then tested on qPCR and compared.   
Statistical Analysis 
 Collected data was analyzed using the frequency procedure of SAS (PROC FREQ) 
(SAS 9.1.3) in order to compile descriptive statistics.  As part of this, a Chi-Square test was 







 Of the 188 swab samples taken, 186 were put onto Trypticase Soy Agar with 5% 
Sheep Blood (TSA II) plates and heart infusion agar base Mycoplasma agar plates.  Table 2 
provides the frequency and percentage of samples that were found to have the presence of 
Mycoplasma, as well as the samples that were found to have an additional pathogen, for each 
feed yard.  The table also indicates the percentage of each organism result as part of the 
entire set of samples.  Table 3 presents similar data for each sample type class.   
 Fifty percent of the samples tested (93 of 186) were positive for Mycoplasma bovis; 
20.43% of which came from samples classified as Repeat.  Additionally, 22.04% of the 
positive samples came from Location 2.   There was no statistical difference among positive 
Mycoplasma tested samples between feed yards (p = 0.75).  The TSA II culture plates were 
examined for four potential pathogens: B. trehalosi, H. somni, M. haemolytica, and P. 
multocida.  Mannheimia heamolytica was found at the greatest frequency of all the pathogens 
with a total of 30 presumptive positive M. haemolytica plates (16.13%).  This was followed 
by H. somni, P. multocida, and B. trehalosi at 5.38%, 4.30%, and 0.54% presumptive 
positive plates respectively.  However, 73.66% of the total samples showed no visual 
presence of the pathogens on the TSA II plate.  These results can be examined along with the 
percentages of each microorganism in Table 2 and Table 3.  
 Table 4 is a representation of the amount of Mycoplasma presence within each 
organism result.  The one B. trehalosi sample was negative for Mycoplasma.  Mannheimia 
haemolytica and H. somni were found more often in Mycoplasma negative samples than 




Table 2: Frequency and Percentage of Organisms Found within Each Feed Yard (n=186)
 Feed Yard   
 Location 1  Location 2  Location 3  Location 4  Location 5  Total 
Organism A1 B2 C3  A1 B2 C3  A1 B2 C3  A1 B2 C3  A1 B2 C3  F4 P5 
TSA II 
Plate6    
 
   
 
   
 
   
 
   
 
  
 Bt 0 0.00 0.00  1 1.22 0.54  0 0.00 0.00  0  0.00 0.00  0  0.00 0.00  1  0.54 
 Hs 3 7.14 1.61  4 4.88 2.15  3 8.57 1.61  0  0.00 0.00  0  0.00 0.00  10  5.38 
 Mh 8 19.05 4.30  13 15.85 6.99  3 8.57 1.61  4 21.05 2.15  2  25.00 1.08  30 16.13 
 Pm 0 0.00 0.00  2 2.44 1.08  5  14.29 2.69  0 0.00 0.00  1  12.50 0.54  8 4.30 
 Neg. 31 73.81 16.67  62 75.61 33.33  24  68.57 12.90  15 78.95 8.06  5 62.50 2.69  137 73.66 
 Total 42 100.00 22.58  82 100.00 44.09  35 100.00 18.82  19 100.00 10.22  8  100.00 4.30  186 100.00 
Myco  7                       
 Pos. 17 40.48 9.14  41 50.00 22.04  20 57.14 10.75  10 52.63 5.38  5 62.50 2.69  93  50.00 
 Neg. 22 52.38 11.83  35 42.68 18.82  15 42.86 8.06  9 47.37 4.84  3 37.50 1.61  84 45.16 
 Con. 3 7.14 1.61  6 7.32 3.23  0  0.00 0.00  0 0.00 0.00  0 0.00 0.00  9 4.84 
 Total 42 100.00 22.58  82 100.00 44.09  35 100.00 18.82  19  100.00 10.22  8 100.00 4.30  186 100.00 
1A = Frequency of samples from each feed yard that possessed the corresponding organism result with the  row  titled total equaling the total number of samples from that feed yard 
2B = Percentage of samples from each feed yard that possessed the corresponding organism result  
3C = Percentage of the total number of samples put on each specific type of culture plate with the row titled total equaling the percentage each feed yard made up of the entire sample size 
tested 
4F = Total frequency of each organism result 
5P = Total percentage each organism result made up for the entire set of samples tested on the specific type of agar plate 
6Trypticase Soy Agar with 5% Sheep Blood; Bt = Bibersteinia trehalosi, Hs = Histophilus somni, Mh = Mannheimia haemolytica, Pm = Pasteurella multocida, Neg. = Negative 





Table 3: Frequency and Percentage of Organisms Found within Each Sample Type (n=186)
 Sample Type1   
 Fresh Cattle  New Pull  Repeat  N/A  Total 
Organism A2 B3 C4  A2 B3 C4  A2 B3 C4  A2 B3 C4  F5 P6 
TSA II Plate7                   
 B. trehalosi 0 0.00 0.00  0 0.00 0.00  1 1.08 0.54  0 0.00 0.00  1 0.54 
 H. somni 3 5.88 1.61  3 10.71 1.61  3 3.23 1.61  1 7.14 0.54  10 5.38 
 M. haemolytica 5 9.80 2.69  5 17.86 2.69  19 20.43 10.22  1 7.14 0.54  30 16.13 
 P. multocida 2 3.92 1.05  1 3.57 0.54  1 1.08 0.54  4 28.57 2.15  8 4.30 
 Negative 41 80.39 22.04  19 67.86 10.22  69 74.19 37.10  8 57.14 4.30  137 73.66 
 Total 51 100.00 27.42  28 100.00 15.06  93 100.00 50.01  14 100.00 7.53  186 100.00 
Mycoplasma bovis                   
 Positive 21 41.18 11.29  22 78.57 11.83  38 40.86 20.43  12 85.71 6.45  93 50.00 
 Negative 29 56.86 15.59  6 21.43 3.23  47 50.54 25.27  2 14.29 1.08  84 45.16 
 Contaminated 1 1.96 0.54  0 0.00 0.00  8 8.60 4.30  0 0.00 0.00  9 4.84 
 Total 51 100.00 27.42  28 100.00 15.06  93 100.00 50.01  14 100.00 7.53  186 100.00 
1Fresh Cattle = clinically healthy and continuing feed yard vaccination protocol, or are new to the feed yard, New Pull = cattle that have been brought to the hospital 
pen for the first treatment based on clinical signs of BRDC, Repeat = brought to the hospital pen at least once before for BRDC treatment, N/A = samples mailed into 
the diagnostic lab with no reference to the state of the cattle they came from 
2A = Frequency of samples from each sample type that possessed the corresponding organism result, with the row titled total equaling the total number of samples 
from that sample type 
3B = Percentage of samples from each sample type that possessed the corresponding organism result 
4C = Percentage of the total number of samples put on each specific type of culture plate with the row titled total equaling the percentage each sample type made up of 
the entire sample size tested 
5F = Total frequency of each organism result 
6P = Total percentage each organism result made up for the entire set of samples tested on the specific type of agar plate 
7Trypticase Soy Agar with 5% Sheep Blood; B. trehalosi = Bibersteinia trehalosi, H. somni = Histophilus somni, M. haemolytica = Mannheimia haemolytica, P. 






Table 4: Frequency and Percentage of Mycoplasma Presence in Samples Testing Positive for 
Additional Organisms (n=186)
 Myco Agar Plate1 
Organism Frequency Percentage of Organism2 Percentage of Entire3 
Bibersteinia trehalosi 0 0.00 0.00 
Histophilus somni 3  30.00 1.61 
Mannheimia haemolytica 12  40.00 6.45 
Pasteurella multocida 7  87.50 3.76 
Negative4 71  51.82 38.17 
Total 93   50.00 
1 Heart infusion agar supplemented with heart infusion broth, thallium acetate, and PP #3 
2Percentage of Mycoplasma presence in the samples testing positive for the specific organism result 
3Percentage of total Myco Agar Plates testing positive for Mycoplasma 




Mycoplasma.  The majority of the Mycoplasma positive samples came from swabs that were 
identified as negative for the four pathogens of interest.  Out of the 93 samples that tested 
positive for Mycoplasma, 71 were negative for the other screened organisms (38.17%).  Nine 
out of the 186 samples were too contaminated to evaluate for Mycoplasma presence.   
 Table 5 and Table 6 examine the Mycoplasma results for each organism within each 
feed yard and sample type respectively.  Out of the 42 samples taken at Location 1, 40.48% 
of the samples were positive for Mycoplasma, of which 41.94% were negative for additional 
potential pathogens.  When comparing the percentages of positive Mycoplasma samples 
across the five feed lots, Location 1 had the lowest percentage of its samples test positive.  
Location 5 had the highest percentage of its total samples test positive for Mycoplasma at 
62.50%, which were five out of the eight samples from that yard.  Four of the five 
Mycoplasma positive samples were also found to be negative for the additional pathogens of 
interest.  Location 3 was the next highest in the percentage of positive Mycoplasma samples 
followed by Location 4 and then Location 2.  Location 2 had half of the 82 samples test 
positive for Mycoplasma.  Most of the samples from Location 2 that were positive for 
Mycoplasma were not found to have one of the other four screened pathogens (33 out of the 
41).  There were 35 samples from Location 3 tested and 57.14% were positive for 
Mycoplasma.  All five of the P. multocida samples from Location 3 were positive for 
Mycoplasma.  Location 4 had 10 out of 19 samples test positive for Mycoplasma, which was 
52.63% of the total for that yard.  Within Location 4 there were four plates that were 
presumptive positive for M. haemolytica, two of them were positive for Mycoplasma. 
 Out of the four sample types, the N/A samples had the largest percentage of its 
samples test positive for Mycoplasma at 85.71% (12 out of 14 samples).  New Pull samples
 
 
Table 5: Frequency and Percentage of Mycoplasma Presence in Samples Testing Positive for Additional Screened Organism 
from each Feed Yard (n=186)













                
Feed 






1 (n=42) 0 0.00 0.00  1 33.33 2.38  3 37.50 7.14  0 0.00 0.00  13 41.94 30.95 17 40.48a 
Location 
2 (n=82)  0 0.00 0.00  2 50.00 2.44  5 38.46 6.10  1 50.00 1.22  33 53.23 40.24 41 50.00a 
Location 
3 (n=35)  0 0.00 0.00  0 0.00 0.00  2 66.67 5.71  5 100.00 14.29  13 54.17 37.14 20 57.14a 
Location 
4 (n=19)   0 0.00 0.00  0 0.00 0.00  2 50.00 10.53  0 0.00 0.00  8 53.33 42.11 10 52.63a 
Location 
5 (n=8)   0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  1 100.00 12.50  4 80.00 50.00 5 62.50a 
1A = Frequency of samples from each feed yard that were positive for specific screened organisms that were also positive for Mycoplasma  
2B = Percentage of the samples from each feed yard positive for specific screened organisms that were also positive for Mycoplasma  
3C = Percentage of the entire samples from each individual feed yard that were positive for Mycoplasma 
4 Total Percentage of samples from the corresponding feed yard that were positive for Mycoplasma 




Table 6: Frequency and Percentage of Mycoplasma Presence in Samples Testing Positive for Additional Screened Organisms 
from each Sample Type (n=186) 
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0 0.00 0.00  2 66.67 7.14  3 60.00 10.71  1 100.00 3.57  16 84.21 57.14 22 78.57 
Repeat 
(n=93) 0 0.00 0.00  1 33.33 1.08  7 36.84 7.53  1 100.00 1.08  29 42.03 31.18 38 40.86 
N/A 
(n=14) 0 0.00 0.00  0 0.00 0.00  1 100.00 7.14  4 100.00 28.57  7 87.50 50.00 12 85.71 
1Fresh Cattle = clinically healthy and continuing feed yard vaccination protocol, or are new to the feed yard, New Pull = cattle that have been brought to the hospital 
pen for the first treatment based on clinical signs of BRDC, Repeat = brought to the hospital pen at least once before for BRDC treatment, N/A = samples mailed into 
the diagnostic lab with no reference to the state of the cattle they came from 
2A = Frequency of samples from each sample type that were positive for specific screened organisms that were also positive for Mycoplasma  
3B = Percentage of the samples from each sample type positive for specific screened organisms that were also positive for Mycoplasma  
4C = Percentage of the entire samples from each individual sample type that were positive for Mycoplasma 





had the next highest percentage of positive Mycoplasma samples at 78.57% of the 28 
samples in that type.  Of the 28 New Pull samples tested, 57.14% were negative for potential 
pathogens and 10.71% were positive for M. haemolytica.  Fresh Cattle swabs had 41.18% 
positive for Mycoplasma.   Only two of the 21 positive Fresh Cattle samples were found to 
have an additional microorganism of interest, one M. haemolytica and one P. multocida.  The 
Repeat sample type had the greatest number of samples tested at 93; only 38 were found to 
have Mycoplasma present (40.86%).  There were 19 positive M. haemolytica samples in the 
repeat sample type (20.43%); seven of which were positive for Mycoplasma (36.84%). 
 The presence of Mycoplasma is further evaluated in Table 7.  The samples are broken 
down by both sample type and feed yard.  Out of all the fresh cattle samples that were 
positive for Mycoplasma presence, 11 of them were taken at Location 2, which was 52.38% 
of samples for fresh cattle.  Location 4 had 9 positive fresh cattle samples equating to 
42.86%.  The last 4.76% came from one sample taken at Location 3.  There were a total of 22 
new pull samples that were positive for Mycoplasma.  Over 50% of these samples were from 
Location 2.  The remaining 10 samples came from Location 3, Location 5, Location 1, and 
Location 4 in that order at four, three, two, and one positive new pull samples respectively.  
Of the 38 Mycoplasma positive repeat samples the majority came from Location 1 and 
Location 2 at 15 and 18 respectively.  Location 1 made up 39.47%, Location 2 47.37%, and 
the remaining came from Location 3 and Location 5 at 7.89% and 5.26% respectively.  All of 
the N/A samples were from Location 3.  The 12 positive N/A samples (all from Location 3) 
made up 60.00% of the Mycoplasma positive samples for that location.  New pull samples 
accounted for 20.00%, repeat 15.00%, and fresh cattle 5.00%.  The majority of the positive 




Table 7: Frequency and Percentage of Mycoplasma Positive Samples Found in Each Sample Type at Each Feed Yard (n=186) 
 Sample Type1 
 Fresh Cattle  New Pull  Repeat  N/A 
Feed Yard A2 B3 C4  A2 B3 C4  A2 B3 C4  A2 B3 C4 
Location 1 0 0.00 0.00  2 11.76 9.09  15 88.24 39.47  0 0.00 0.00 
Location 2 11 26.83 52.38  12 29.27 54.55  18 43.90 47.37  0 0.00 0.00 
Location 3 1 5.00 4.76  4 20.00 18.18  3 15.00 7.89  12 60.00 100.00 
Location 4 9 90.00 42.86  1 10.00 4.55  0 0.00 0.00  0 0.00 0.00 
Location 5 0 0.00 0.00  3 60.00 13.64  2 40.00 5.26  0 0.00 0.00 
1Fresh Cattle = clinically healthy and continuing feed yard vaccination protocol, or are new to the feed yard, New Pull = cattle that 
have been brought to the hospital pen for the first treatment based on clinical signs of BRDC, Repeat = brought to the hospital pen at 
least once before for BRDC treatment, N/A = samples mailed into the diagnostic lab with no reference to the state of the cattle they 
came from 
2A = Frequency of Mycoplasma positive samples for each of the different sample types within the samples gathered from each feed 
yard 
3B = Percentage of the  Mycoplasma positive samples for the entire feed yard that came from the corresponding sample type 






came from new pull samples.  Location 2 positives were distributed over three sample types; 
fresh cattle, new pull, and repeat at 26.83%, 29.27%, and 43.90% respectively.  Almost all of 
the Mycoplasma positive samples from Location 4 came from fresh cattle at 90.00%.   
Location 5 was split between new pull and repeat samples, with repeat accounting for 
40.00% and new pull accounting for 60.00%. 
 Table 8 is similar to Table 7 in that it is showing the same type of data except in 
relation to the different organisms found instead of Mycoplasma presence.  As previously 
mentioned there was only one B. trehalosi found, so consequently 100.00% came from 
Location 2 and it was a repeat sample.  Of the nine samples identified to have H. somni 
present, three were repeat samples from Location 1.  These were the only three H. somni 
samples identified from those taken at Location 1; they were also the only three repeat 
samples to have H. somni.  Location 2 had four samples with H. somni present, evenly 
distributed between fresh cattle and new pulls. These both made up 66.67% of the H. somni 
found in each respective sample type.  Location 3 also had an even distribution of H. somi 
among fresh cattle and new pull sample types at one each.  This made up the remaining 
33.33% for the sample types. 
 There was a higher prevalence of M. haemolytica compared to the other screened 
organisms among the samples tested.  All eight M. haemolytica positive samples from 
Location 1 were from repeat samples. Additionally, these eight made up 42.11% of  
M. haemolytica found among repeat samples.  The M. haemolytica positives found within 
Location 2 samples were from fresh cattle, new pulls, and repeats with repeat having the 
highest number at 10, making up 76.92%.  These 10 samples accounted for 52.63% of repeat 
samples positive for M. haemolytica.  The fresh cattle M. haemolytica samples made up
 
 
Table 8: Frequency and Percentage of Organisms Found in Each Sample Type at Each Feed Yard (n=186) 
 Organism 
 Bibersteinia trehalosi  Histophlius somni  Mannheimia Haemolytica  Pasteurella multocida  Negative 
Feed Yard/ 
Sample 
Type1 A2 B3 C4  A2 B3 C4  A2 B3 C4  A2 B3 C4  A2 B3 C4 
Location 1 
 Fresh Cattle 0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00 
 New Pull 0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  4 12.90 21.05 
 Repeat 0 0.00 0.00  3 100.00 100.00  8 100.00 42.11  0 0.00 0.00  27 87.10 39.13 
 N/A 0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00 
Location 2 
 Fresh Cattle 0 0.00 0.00  2 50.00 66.67  2 15.38 40.00  1 50.00 50.00  18 29.03 43.90 
 New Pull 0 0.00 0.00  2 50.00 66.67  1 7.69 20.00  0 0.00 0.00  9 14.52 47.37 
 Repeat 1 100.00 100.00  0 0.00 0.00  10 76.92 52.63  1 50.00 100.00  35 56.45 50.72 
 N/A 0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00 
Location 3  
 Fresh Cattle 0 0.00 0.00  1 50.00 33.33  1 33.33 20.00  1 20.00 50.00  8 33.33 19.51 
 New Pull 0 0.00 0.00  1 50.00 33.33  1 33.33 20.00  0 0.00 0.00  4 16.67 21.05 
 Repeat 0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  4 16.67 5.80 
 N/A 0 0.00 0.00  0 0.00 0.00  1 33.33 100.00  4 80.00 100.00  8 33.33 100.00 
Location 4 
 Fresh Cattle 0 0.00 0.00  0 0.00 0.00  2 50.00 40.00  0 0.00 0.00  15 100.00 36.59 
 New Pull 0 0.00 0.00  0 0.00 0.00  2 50.00 40.00  0 0.00 0.00  0 0.00 0.00 
 Repeat 0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00 
 N/A 0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00 
Location 5 
 Fresh Cattle 0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00 
 New Pull 0 0.00 0.00  0 0.00 0.00  1 50.00 20.00  1 100.00 100.00  2 40.00 10.53 
 Repeat 0 0.00 0.00  0 0.00 0.00  1 50.00 5.26  0 0.00 0.00  3 60.00 4.35 
 N/A 0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00  0 0.00 0.00 
1Fresh Cattle = clinically healthy and continuing feed yard vaccination protocol, or are new to the feed yard, New Pull = cattle that have been brought to the hospital pen 
for the first treatment based on clinical signs of BRDC, Repeat = brought to the hospital pen at least once before for BRDC treatment, N/A = samples mailed into the 
diagnostic lab with no reference to the state of the cattle they came from 
2A = Frequency of the organisms identified for each of the different sample types within the samples gathered from each feed yard 
3B = Percentage of the specific organism identified for the entire feed yard samples that came from the specific sample type 





15.38% of those from Location 2, and the remaining 7.69% was the one sample that was in 
the new pull category.  Location 2 accounted for 40.00% of the entire M. haemolytica 
positive fresh cattle samples and 20.00% of the entire new pull samples positive for M. 
haemolytica.  The M. haemolytica samples from Location 3 were evenly distributed among 
fresh cattle, new pull, and N/A each having one positive.  This accounted for 20.00% of M. 
haemolytica positive samples for both fresh cattle and new pull sample types.  Again there 
was an even distribution among sample types for both Location 4 and Location 5.  Location 4 
had two samples from fresh cattle and two from new pull samples that were positive for M. 
haemolytica.  Both of these accounted for 40.00% of the positive samples for each respective 
type.  Location 5 had one sample with M. haemolytica present in both new pull and repeat 
sample types.  The one new pull made up 20.00% of all new pull M. haemolytica positive 
samples, and the one repeat accounted for 5.26% of all repeat M. haemolytica positive 
samples. 
 Pasteurella multocida was found in eight samples from three different feed yards and 
in all four sample types.  At Location 2 there were two samples found to be positive, one 
fresh cattle sample and one repeat sample. This was the only repeat sample found to have P. 
multocida, and the Location 2 fresh cattle sample accounted for 50.00% of all P. multocida 
positive fresh cattle samples.  Location 3 had five total P. multocida samples, four N/A 
sample types making up 80.00% of those from Location 3, and one fresh cattle sample type 
accounting for the remaining 20.00% for that feed yard and the remaining 50.00% for the 
sample type.  Location 5 only had one sample show presence of P. multocida.  This was a 
new pull sample, and was the only new pull sample to be positive for P. multocida.  The 




primary pathogens is also shown in table eight.      
qPCR Detection and Development 
 The extraction and qPCR detection process was performed on 186 of the 188 
samples, as two of the original samples were lost during transport.  Of the 186, two samples 
were able to report a threshold cycle (Ct) score all other samples had undetermined results at 
a threshold of 0.5.  The Ct  scores for the two positive samples were 34.43 and 30.65 
respectively.  All samples were evaluated again at the threshold automated by the qPCR run 
resulting in one other sample having a Ct score.  This third sample’s score was reported at 
31.96.  The three samples that garnered a Ct score were evaluated on the TSA II plates, and 
the colonies that were suspected to be B. trehalosi were isolated and grown on a separate 
plate and TSTB tubes, re-extracted and run on qPCR again.  In total there were seven 
samples that were regrown and extracted a second time to be run on qPCR; these included 
the three with a Ct score from the original sample, and four that had a colony suspected to be 
B. trehalosi based on colony morphology and a negative catalase reaction. 
 The second run of PCR on these samples resulted in Ct values of 16.9 for one of the 
four original samples suspected to have a B. trehalosi colony and 27.55 for one of the 
original three samples that reported a Ct score, all others came back undetermined at a 
threshold of 0.5.  When all seven of the retest samples were run on PCR and gel 
electrophoresis, no bands were formed, ruling out the possibility of the samples being M. 
haemolytica.  All of the samples were also retested with the biochemical agents resulting in 
only one sample having the B. trehalosi results of indole negative, oxidase positive, and 
catalase negative.  All other samples did not have biochemical results correlating with any of 




threshold of 0.5, the proper colony morphology, and proper biochemical test results, was one 
originally identified by suspected colony morphology.  This sample had an agglutination test 
done in order to serotype, resulting in it being confirmed type T3 with a slight possibility of 
T10.  Table 9 displays the results of all the tests run on the samples that were tested twice. 
 Sensitivity trials were run on the developed qPCR assay.  The first test resulted in the 
original undiluted B. trehalosi extracted sample having a Ct value of 18.93 and the first log 
dilution 30.6, at a threshold of 0.5.  The remaining seven dilutions came back undetermined.  
The second sensitivity trial had the following results at a threshold of 0.5: lightly inoculated 
undiluted sample of 19.25, light dilution one of 30.3, heavily inoculated undiluted sample  of 
16.05, and heavy dilution one of 26.83.  Again, all other dilutions came back undetermined.  
The original colony count prior to dilution was 2.8 x 107.  
 The Qiagen extraction method was not run on qPCR because quantification of 
extracted DNA came back to be comparable to that of the Promega samples.  DNA 
concentration levels of Qiagen extractions were at 8.84ng/µl of DNA for the lightly 
inoculated tube and 5.52ng/µl of DNA for the heavy inoculated tube compared to 2.35ng/µl 
and 4.68ng/µl for the Promega samples. However, the first dilution of the Qiagen extracted 
samples had a small amount of detectable DNA when quantified, whereas all of the dilutions 




Table 9: Results of All Tests Done on Samples with Possibility of Being Bibersteinia 
trehalosi 
 
 Initial Tests1  Re-test2  Additional Tests3 
Sample 





Biochemical Tests6 PCR/Gel7 Serotype 
B957G Negative 34.43  Undetermined  I: - O: - C: + (N/A) No bands  
K 1147 (B. trehalosi)8 Undetermined  Undetermined  I: - O: - C: + (N/A) No bands  
K 1991 M. haemolytica9 31.9610  27.55  I: - O: - C: + (N/A) No bands  
K 4372 (B. trehalosi)8 Undetermined  16.9  I: - O: + C: - (B. trehalosi)8 No bands T3 (possibly T10) 
K 7029 Negative 30.65  Undetermined  I: - O: - C: - (N/A) No bands  
K 2465 (B. trehalosi)8 Undetermined  Undetermined  I: - O: - C: + (N/A) No bands  
PV 15 (B. trehalosi)8 Undetermined  Undetermined  I: - O: - C: - (N/A) No bands  
1 The tests conducted on the original swab and extracted sample 
2 The tests conducted on selected isolated colonies that were regrown after initial testing 
3 Additional tests conducted on the regrown samples in order to further confirm organism identification 
4 Trypticase Soy Agar with 5% Sheep Blood 
5 Threshold Cycle score at a threshold of 0.5 
6 I=indole, O=oxidase, C=catalase, - = Negative, + = Positive 
7 PCR assay for Mannheimia haemolytica with the reactions visualized on an 1.5% agarose gel 
8 B. trehalosi=Bibersteinia trehalosi 
9 M. haemolytica=Mannheimia haemolytica 
10 Threshold cycle score at the automated threshold 






 This is the first known study directed at prevalence data for Bibersteinia trehalosi (B. 
trehalosi) housed in the nasopharynx portion of the upper respiratory tract of cattle in the 
United States.  Additionally, the development of a B. trehalosi selective assay for qPCR has 
not yet been done.  B. trehalosi, formerly known as Pasteurella trehalosi, is originally from 
the complex of species that was known as the Pasteurella haemolytica complex (Blackall et 
al., 2007).  As noted in previous studies, B. trehalosi is a common respiratory pathogen of 
sheep, specifically bighorn sheep (Dassanayake et al., 2013, Fernández et al., 2016, Kugadas 
et al., 2016, Miller et al., 2013, Walsh et al., 2016).  The possibility of detecting the organism 
before it gets to the lungs of cattle would be beneficial in the prevention of an infection.   
 Mannheimia haemolytica (M. haemolytica) and B. trehalosi are closely related, as M. 
haemolytica was also originally part of the Pasteurella haemolytica complex prior to 
reclassification through phylogenetic studies (Blackall et al., 2007, Klima et al., 2017).  The 
relation between the two organisms was also confirmed in a study done in 2011 on the tbpBA 
operon of the two organisms.  Through the research conducted, evidence of a common gene 
pool was made by showing various regions of the operon being shared by both M. 
haemolytica and B. trehalosi (Lee et al., 2011). This genetic association of the two organisms 
is where the current standards of detection stem from.  Dassanayake et al. (2009) developed 
the multiplex assay used to differentiate between B. trehalosi and M. haemolytica.   The O-
sialoglycoprotein endopeptidase (gcp) and manganese-dependent superoxide dismutase 
(sodA) portions of the two organisms’ sequences were aligned.  This allowed for the 
production of species specific primer sets, using the gcp portion for M. haemolytica and the 




electrophoresis where the bands would determine if a sample were M. haemolytica or B. 
trehalosi.  These portions of the genomes are where the potential qPCR assay design of the 
current study began.  Due to lack of specificity for B. trehalosi alone, the region used for the 
primer set was found elsewhere.   
 One attribute that distinguishes B. trehalosi from M. haemolytica is its ability to 
ferment trehalose (Blackall et al., 2007).  While the exact gene that codes for this process 
was not known, the idea was to find the sequence that allows for this process to occur, in 
order to try and separate the two microorganisms.  With that thought in mind the PTS 
trehalose transporter subunit IIBC was selected to use as the source of the primer sequences 
for the current study.   
 The ability of the assay to only detect amplifiable DNA from the first log dilution 
during the sensitivity trials; indicates that the assay can detect the presence of the bacteria 
when there are approximately six logs present in the initial extraction process.  In order to 
improve this attribute of the assay, additional extraction methods could be explored such as; 
the QIAamp DNA minikit (Qiagen), Genomic-tip 100/G columns and buffers (Qiagen), and 
the use of InstaGene Matrix (Bio-Rad) with the harvest of one milliliter of cells by 
centrifugation, all of which were used in previous studies involving B. trehalosi (Anton et al., 
2016, Kugadas et al., 2016, Lee et al., 2012).  Additional ideas for improvement include an 
enrichment of the initial swab sample taken, or placing the swab on a Trypticase™ Soy Agar 
with 5% Sheep Blood  (TSA II) plate.   Isolation of a potential colony would then be required 
and the bacteria grown up in a broth, similar to what was done with the retest culture samples 





 Threshold cycle scores being reported for samples that were not found to be B. 
trehalosi indicates that the primer set is not specific to Bibersteinia alone.  Further research 
should be conducted looking into possible DNA sequences that are unique to B. trehalosi.   
Klima et al. (2017) explored creating a multiplex PCR primer for Mannheimia species 
associated with BRD.  In that study the gene targets were associated with the capsular 
polysaccharide or the lipopolysaccharide biosynthesis in order to distinguish between 
serotypes. This proved to be able to correctly identify three different serotypes of M. 
haemolytica; it is possible that the same area of the B. trehalosi genome can lead to a more 
specific assay.  Likewise, Guenther et al. (2008) developed a qPCR assay specific to 
Mannheimia species by using the sodA gene previously mentioned.  Though this gene was 
originally targeted for the primer sequence in this study, more intensive research could be 
done as it has proven to be successful for other specific assays (Guenther et al., 2008).  
 Since only one B. trehalosi was found out of the 188 samples taken utilizing PCR or 
traditional culture methods, it is unlikely that the microorganism is prevalent in the 
nasopharynx of cattle.  Dassanayake et al. (2009) suggests that B. trehalosi can outgrow and 
even inhibit the growth of M. haemolytica in the lungs of bighorn sheep.  This combined with 
B. trehalosi being an opportunistic bacterium could potentially explain why there is an 
increase in the appearance of the organism in the lungs of BRDC infected cattle.  
Additionally, it has been hypothesized that an increase in pathogenicity of Bibersteinia was 
acquired from other bacteria and is related to the genetic similarities.  For instance, B. 
trehalosi and M. haemolytica share the pathogenic characteristic of the lktA gene, which is 
important in the expression of leukotoxin, a major virulence factor (Bowersock et al., 2014, 




trehalosi, the results indicated that the pathogen may not be of primary importance and is a 
more opportunistic bacterium.  In this study there were 12 calves inoculated intranasally with 
B. trehalosi or a combination of B. trehalosi and M. haemolytica.  Of the 12 cattle, only one 
lung had B. trehalosi isolated from the tissue indicating that the bacteria isolates used in the 
study were not associated with significant disease in that research setting.  Prior to the study, 
nasopharyngeal swabs of the calves did not find Bibersteinia to be present (Hanthorn et al., 
2014).    
 In a study conducted on live export cattle in Australia, the prevalence of viral and 
bacterial agents associated with BRDC in nasal shedding was evaluated.  In that study 1,484 
nasal swabs were taken and examined for BHV, BRSV, PI-3, BVDV 1, Bovine Corona 
Virus, Histophilus somni (H. somni), Pasteurella multocida (P. multocida), M. haemolytica 
and Mycoplasma bovis.  Though B. trehalosi was not tested for, the results of the study help 
in comparison of the other organisms examined for in the current study.  The result for 
percentage of M. haemolytica presence was comparable to the current study at 13%, which 
was in the range of previously reported prevalence data (2-33%).  Pastuerella multocida 
presence was higher compared to the current study as was H. somni (Moore et al. 2015).  On 
the other hand, Mycoplasma bovis presence was greater in the current study when compared 
and was higher than the range of 0% to 43% previously reported by Moore et al. (2015).  In a 
research review from 2009, it was reported that healthy feedlot cattle shed Mycoplasma bovis 
from the nasal passages, and approximately 50% of cattle have Mycoplasma present upon 
entering the feedlot; similar results were found with this study.  Additionally, it has been 
reported that cattle that have been previously treated for BRDC have the highest percentage 




samples had a greater presence of Mycoplasma positive samples when comparing to the 
percentage of the Repeat samples.   
 Holman et al. (2015) conducted a study in Canada with the objective of studying the 
total microbiota in the nasopharynx of feedlot cattle using the 16s rRNA gene.  Again, B. 
trehalosi was not looked for in this study, although M. haemolytica, P. multocida, and H. 
somni were.  It was found that 10.6% of all the bacterial isolates on non-selective media were 
Mannheimia species (Holman et al. 2015).  
 In conclusion, the prevalence of B. trehalosi in the nasopharynx of feedlot cattle is 
low, suggesting that it is not a primary pathogen in cattle.  At the current rate of 0.54% 
prevalence as detected by this study, there is not a great need for a specific qPCR assay.  The 
further development of the assay may be beneficial for the sheep industry as the organism is 
considered a primary pathogen, and is found at a higher prevalence.  If B. trehalosi 
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Recipe for Tryptic Soy Tryptose Broth (TSTB) (500ml) for Seed Tubes: 
 Add the following to a sterile Erlenmeyer flask with a stir bar: 
  15g of Tryptic Soy Broth 
  2.5g of tryptose 
  500ml of sterile RO water 
 Stir thoroughly on a stir plate 
 Aliquot 15ml into test tubes 
 Sterilize for 20 minutes at ˃ 121°C in an autoclave. 


















Recipe for Mycoplasma agar (1 liter): 
 Add the following to a sterile 2L Erlenmeyer flask with stir bar: 
  25g heart infusion agar 
  10g heart infusion broth 
  10g PP#3 
  0.25g thallium acetate 
  900ml sterile RO water 
 Mix thoroughly with heated stir plate. 
 Adjust pH of agar to 7.9 using 5M NaOH and 5M HCl. 
 Autoclave at ˃ 121°C for 20 minutes with slow exhaust. 
 After autoclaving, place in water bath preheated to 56°C for 30 minutes. 
 Allow to cool before adding the following: 
  126ml heat inactivated equine sera 
  100ml sterile yeast extract 
  21ml DPN-cysteine 
  0.635g Penicillin G (do not add when broth is hot as penicillin will curdle) 
 Mix thoroughly until Penicillin G dissolves. 
 Aliquot into petri dishes. (~7ml per small petri dish, ~55ml per large petri dish) 
 Allow plates to cool overnight before placing into refrigerator. 
